Pacer Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.5M | Buy |
42,906
+20,561
| +92% | +$6.45M | 0.03% | 396 |
|
2025
Q1 | $6.81M | Buy |
22,345
+9,860
| +79% | +$3M | 0.02% | 552 |
|
2024
Q4 | $4.15M | Buy |
12,485
+3,616
| +41% | +$1.2M | 0.01% | 672 |
|
2024
Q3 | $2.96M | Sell |
8,869
-5,099
| -37% | -$1.7M | 0.01% | 798 |
|
2024
Q2 | $5.75M | Buy |
13,968
+9,022
| +182% | +$3.72M | 0.01% | 541 |
|
2024
Q1 | $2M | Buy |
4,946
+1,441
| +41% | +$582K | ﹤0.01% | 861 |
|
2023
Q4 | $1.07M | Sell |
3,505
-2,036
| -37% | -$624K | ﹤0.01% | 1107 |
|
2023
Q3 | $1.34M | Sell |
5,541
-857
| -13% | -$208K | 0.01% | 722 |
|
2023
Q2 | $1.54M | Buy |
6,398
+4,050
| +172% | +$973K | 0.01% | 835 |
|
2023
Q1 | $442K | Sell |
2,348
-2,486
| -51% | -$467K | ﹤0.01% | 1174 |
|
2022
Q4 | $1.03M | Buy |
4,834
+3,043
| +170% | +$646K | 0.01% | 816 |
|
2022
Q3 | $281K | Buy |
1,791
+1,402
| +360% | +$220K | ﹤0.01% | 1425 |
|
2022
Q2 | $58K | Buy |
389
+46
| +13% | +$6.86K | ﹤0.01% | 2092 |
|
2022
Q1 | $56K | Sell |
343
-4,509
| -93% | -$736K | ﹤0.01% | 2231 |
|
2021
Q4 | $1.06M | Buy |
4,852
+1,700
| +54% | +$370K | 0.01% | 1166 |
|
2021
Q3 | $597K | Buy |
3,152
+38
| +1% | +$7.2K | 0.01% | 1058 |
|
2021
Q2 | $550K | Sell |
3,114
-14
| -0.4% | -$2.47K | 0.01% | 1101 |
|
2021
Q1 | $513K | Buy |
3,128
+24
| +0.8% | +$3.94K | 0.01% | 1049 |
|
2020
Q4 | $432K | Sell |
3,104
-3,173
| -51% | -$442K | 0.01% | 1026 |
|
2020
Q3 | $701K | Buy |
+6,277
| New | +$701K | 0.01% | 863 |
|
2020
Q1 | – | Sell |
-7,534
| Closed | -$633K | – | 930 |
|
2019
Q4 | $633K | Buy |
+7,534
| New | +$633K | 0.03% | 712 |
|
2019
Q3 | – | Sell |
-10,566
| Closed | -$691K | – | 1191 |
|
2019
Q2 | $691K | Sell |
10,566
-648
| -6% | -$42.4K | 0.02% | 911 |
|
2019
Q1 | $661K | Buy |
+11,214
| New | +$661K | 0.02% | 528 |
|